Fingerprint
Dive into the research topics of 'Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia
Alan K Burnett, Nigel H Russell, Robert K Hills, Jonathan Kell, Sylvie Freeman, Lars Kjeldsen, Ann E Hunter, John Yin, Charles Craddock, Inge Hoegh Dufva, Keith Wheatley, Donald Milligan
Research output: Contribution to journal › Article › peer-review
266
Citations
(Scopus)